3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3
- PMID: 15963723
- DOI: 10.1016/j.bmcl.2005.05.084
3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3
Abstract
Copper(I)-catalyzed addition of alkynes to methyl 3-azido-3-deoxy-1-thio-beta-D-galactopyranoside afforded stable and structurally simple 3-deoxy-3-(1H-1,2,3-triazol-1-yl)-1-thio-galactosides carrying a panel of substituents at the triazole C4 in high yields. The 3-(1H-[1,2,3]-triazol-1-yl)-1-thio-galactoside collection synthesized contained inhibitors of the tumor- and inflammation-related galectin-3 with Kd values as low as 107 microM, which is as potent as the natural disaccharide inhibitors lactose and N-acetyllactosamine.
Similar articles
-
Arginine binding motifs: design and synthesis of galactose-derived arginine tweezers as galectin-3 inhibitors.J Med Chem. 2008 Apr 10;51(7):2297-301. doi: 10.1021/jm701266y. Epub 2008 Mar 5. J Med Chem. 2008. PMID: 18318467
-
Aryl O- and S-galactosides and lactosides as specific inhibitors of human galectins-1 and -3: role of electrostatic potential at O-3.Bioorg Med Chem Lett. 2006 Mar 15;16(6):1668-72. doi: 10.1016/j.bmcl.2005.12.010. Epub 2006 Jan 5. Bioorg Med Chem Lett. 2006. PMID: 16403629
-
1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.Bioorg Med Chem. 2010 Jul 15;18(14):5367-78. doi: 10.1016/j.bmc.2010.05.040. Epub 2010 May 20. Bioorg Med Chem. 2010. PMID: 20538469
-
Synthesis of stable and selective inhibitors of human galectins-1 and -3.Bioorg Med Chem. 2008 Aug 15;16(16):7811-23. doi: 10.1016/j.bmc.2008.06.044. Epub 2008 Jun 26. Bioorg Med Chem. 2008. PMID: 18674915
-
Inhibition of galectins with small molecules.Chimia (Aarau). 2011;65(1-2):18-23. doi: 10.2533/chimia.2011.18. Chimia (Aarau). 2011. PMID: 21469439 Review.
Cited by
-
Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.Endocrine. 2006 Jun;29(3):435-44. doi: 10.1385/ENDO:29:3:435. Endocrine. 2006. PMID: 16943582
-
Galectins as Molecular Targets for Therapeutic Intervention.Int J Mol Sci. 2018 Mar 19;19(3):905. doi: 10.3390/ijms19030905. Int J Mol Sci. 2018. PMID: 29562695 Free PMC article. Review.
-
Sequence-Defined Heteromultivalent Precision Glycomacromolecules Bearing Sulfonated/Sulfated Nonglycosidic Moieties Preferentially Bind Galectin-3 and Delay Wound Healing of a Galectin-3 Positive Tumor Cell Line in an In Vitro Wound Scratch Assay.Macromol Biosci. 2020 Sep;20(9):e2000163. doi: 10.1002/mabi.202000163. Epub 2020 Jul 26. Macromol Biosci. 2020. PMID: 32715650 Free PMC article.
-
Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1.J Pharmacol Exp Ther. 2013 Mar;344(3):589-99. doi: 10.1124/jpet.112.199646. Epub 2012 Dec 11. J Pharmacol Exp Ther. 2013. PMID: 23232447 Free PMC article.
-
Protein flexibility and conformational entropy in ligand design targeting the carbohydrate recognition domain of galectin-3.J Am Chem Soc. 2010 Oct 20;132(41):14577-89. doi: 10.1021/ja105852y. J Am Chem Soc. 2010. PMID: 20873837 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Miscellaneous